关注
Colin Charnock
Colin Charnock
Professor
在 oslomet.no 的电子邮件经过验证
标题
引用次数
引用次数
年份
Dietary fiber, gut microbiota, and metabolic regulation—Current status in human randomized trials
MCW Myhrstad, H Tunsjø, C Charnock, VH Telle-Hansen
Nutrients 12 (3), 859, 2020
2352020
Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis
LL Gundersen, C Charnock, AH Negussie, F Rise, S Teklu
European journal of pharmaceutical sciences 30 (1), 26-35, 2007
1732007
Assimilable organic carbon and biodegradable dissolved organic carbon in Norwegian raw and drinking waters
C Charnock, O Kjønnø
Water Research 34 (10), 2629-2642, 2000
1422000
A preliminary study on the potential of Nanopore MinION and Illumina MiSeq 16S rRNA gene sequencing to characterize building-dust microbiomes
AB Nygaard, HS Tunsjø, R Meisal, C Charnock
Scientific Reports 10 (1), 3209, 2020
1352020
Antimicrobial and cytotoxic activity of agelasine and agelasimine analogs
A Vik, E Hedner, C Charnock, LW Tangen, Ø Samuelsen, R Larsson, ...
Bioorganic & medicinal chemistry 15 (12), 4016-4037, 2007
1032007
(+)-Agelasine D: improved synthesis and evaluation of antibacterial and cytotoxic activities
A Vik, E Hedner, C Charnock, Ø Samuelsen, R Larsson, LL Gundersen, ...
Journal of natural products 69 (3), 381-386, 2006
852006
Are multidose over-the-counter artificial tears adequately preserved?
C Charnock
Cornea 25 (4), 432-437, 2006
822006
Combining esters of para‐hydroxy benzoic acid (parabens) to achieve increased antimicrobial activity
C Charnock, T Finsrud
Journal of clinical pharmacy and therapeutics 32 (6), 567-572, 2007
812007
Evaluation of the antibacterial efficacy of diesters of azelaic acid
C Charnock, B Brudeli, J Klaveness
European journal of pharmaceutical sciences 21 (5), 589-596, 2004
782004
Synthesis, Antimicrobial and Antineoplastic Activities for Agelasine and Agelasimine Analogs with a β‐Cyclocitral Derived Substituent
A Proszenyak, C Charnock, E Hedner, R Larsson, L Bohlin, ...
Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal …, 2007
472007
Swabbing of waiting room magazines reveals only low levels of bacterial contamination
C Charnock
British journal of general practice 55 (510), 37-39, 2005
442005
Synthesis of non-purine analogs of 6-aryl-9-benzylpurines, and their antimycobacterial activities. Compounds modified in the imidazole ring
AD Khoje, A Kulendrn, C Charnock, B Wan, S Franzblau, LL Gundersen
Bioorganic & medicinal chemistry 18 (20), 7274-7282, 2010
412010
Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles
AD Khoje, C Charnock, B Wan, S Franzblau, LL Gundersen
Bioorganic & medicinal chemistry 19 (11), 3483-3491, 2011
382011
Microbial quality and nutritional aspects of Norwegian brand waters
E Otterholt, C Charnock
International journal of food microbiology 144 (3), 455-463, 2011
342011
Antimicrobial and Antineoplastic Activities of Agelasine Analogs Modified in the Purine 2‐Position
H Roggen, C Charnock, R Burman, J Felth, R Larsson, L Bohlin, ...
Archiv der Pharmazie 344 (1), 50-55, 2011
332011
Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines
M Brændvang, C Charnock, LL Gundersen
Bioorganic & medicinal chemistry letters 19 (12), 3297-3299, 2009
322009
The first synthesis of ent-agelasine F
Á Proszenyák, M Brændvang, C Charnock, LL Gundersen
Tetrahedron 65 (1), 194-199, 2009
322009
Activity of 6-aryl-pyrrolo [2, 3-d] pyrimidine-4-amines to Tetrahymena
SJ Kaspersen, E Sundby, C Charnock, BH Hoff
Bioorganic chemistry 44, 35-41, 2012
302012
Longitudinal development of the dust microbiome in a newly opened Norwegian kindergarten
AB Nygaard, C Charnock
Microbiome 6, 1-11, 2018
292018
Identification and phylogeny of the small eukaryote population of raw and drinking waters
E Otterholt, C Charnock
Water research 45 (8), 2527-2538, 2011
282011
系统目前无法执行此操作,请稍后再试。
文章 1–20